NCT01718951View on ClinicalTrials.gov

Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

October 31, 2014

Conditions
Spondyloarthropathy
Interventions
DRUG

golimumab

golimumab

DRUG

Pamidronate

pamidronate

Trial Locations (1)

Unknown

Tuen Mun Hospital, Hong Kong

All Listed Sponsors
lead

Tuen Mun Hospital

OTHER_GOV

NCT01718951 - Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial | Biotech Hunter | Biotech Hunter